{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:37:43Z","timestamp":1793144263780,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.compbiomed.2025.111067","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T07:09:46Z","timestamp":1757660986000},"page":"111067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"PB","title":["Advancements in breast cancer therapy: Integrating AI tools for drug discovery and clinical trials"],"prefix":"10.1016","volume":"197","author":[{"given":"Vinita","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-2607","authenticated-orcid":false,"given":"Gopal","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-7510","authenticated-orcid":false,"given":"Udit","family":"Chaube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.111067_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.compbiomed.2025.111067_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105401","article-title":"Understanding breast cancer: from conventional therapies to repurposed drugs","volume":"151","author":"Costa","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib3","article-title":"Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low\/positive advanced breast cancer: a single-arm meta-analysis","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1228865","article-title":"Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach","volume":"13","author":"Akash","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173452","article-title":"In vivo efficacy studies of chromene-based compounds in triple-negative breast cancer \u2013 a systematic review","volume":"887","author":"Oliveira-Pinto","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176328","article-title":"Investigation of co-treatment multi-targeting approaches in breast cancer cell line","volume":"966","author":"Longaray","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-20301-6_4","article-title":"Breast cancer: current perspectives on the disease status","volume":"1152","author":"Fahad Ullah","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173725","article-title":"Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo","volume":"891","author":"Pateliya","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anti-cancer activities: an overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.265","article-title":"Understanding and targeting resistance mechanisms in cancer","volume":"4","author":"Lei","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.compbiomed.2025.111067_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to paclitaxel resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.compbiomed.2025.111067_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112356","article-title":"Resveratrol \u2013 a comprehensive review of recent advances in anticancer drug design and development","volume":"200","author":"Ahmadi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174266","article-title":"Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: an update with promising analogues","volume":"906","author":"Adeluola","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2023.101332","article-title":"Computer-aided drug design in anti-cancer drug discovery: what have we learnt and what is the way forward","volume":"41","author":"Iwaloye","year":"2023","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.compbiomed.2025.111067_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbcan.2005.07.005","article-title":"A new frontier for molecular medicine: noncoding RNAs","volume":"1756","author":"Szymanski","year":"2005","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"10.1016\/j.compbiomed.2025.111067_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172407","article-title":"LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway","volume":"856","author":"Sun","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib17","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1200\/JCO.19.02488","article-title":"HER2-low breast cancer: pathological and clinical landscape","volume":"38","author":"Tarantino","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1200\/JCO.19.01455","article-title":"NSABP B-47\/NRG oncology phase III randomized trial comparing adjuvant chemotherapy with or without trastuzumab in high-risk invasive breast cancer negative for HER2 by FISH and with IHC 1+ or 2+","volume":"38","author":"Fehrenbacher","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib19","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1158\/1078-0432.CCR-08-1056","article-title":"HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer","volume":"14","author":"Press","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2010.29.5865","article-title":"Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy","volume":"29","author":"Burris 3rd","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/life12010048","article-title":"Comparison of anticancer drug toxicities: paradigm shift in adverse effect profile","volume":"12","author":"Basak","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.compbiomed.2025.111067_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42269-021-00690-z","article-title":"In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line","volume":"46","author":"Abdullahi","year":"2022","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.compbiomed.2025.111067_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115199","article-title":"Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase inhibitors in cancers","volume":"250","author":"Wen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib24","article-title":"CADD, AI, and ML in drug discovery: a comprehensive review","volume":"181","author":"Vemula","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.33545\/26647591.2024.v6.i1a.76","article-title":"Computer aided drug design for breast cancer","volume":"6","author":"Devi","year":"2024","journal-title":"Int. J. Pharm. Clin. Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ph17010022","article-title":"Computer-aided drug design and drug discovery: a prospective analysis","volume":"17","author":"Niazi","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.compbiomed.2025.111067_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s12257-020-0049-y","article-title":"Artificial intelligence in drug discovery: a comprehensive review of data-driven and machine learning approaches","volume":"25","author":"Kim","year":"2020","journal-title":"Biotechnol. Bioproc E."},{"key":"10.1016\/j.compbiomed.2025.111067_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113705","article-title":"Current trends in computer-aided drug design and a highlight of drugs discovered via computational techniques: a review","volume":"224","author":"Sabe","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/17460441003592072","article-title":"Pharmacophore-based virtual screening: a review of recent applications","volume":"5","author":"Kim","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111067_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13321-020-00419-6","article-title":"Multiobjective de novo drug design with recurrent neural networks and nondominated sorting","volume":"12","author":"Yasonik","year":"2020","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2025.111067_bib31","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.fmre.2024.04.021","article-title":"Role of artificial intelligence in revolutionizing drug discovery","volume":"5","author":"Rehman","year":"2025","journal-title":"Fundam. Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib32","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.compbiomed.2025.111067_bib33","author":"Vose"},{"key":"10.1016\/j.compbiomed.2025.111067_bib34","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","article-title":"Analyzing learned molecular representations for property prediction","volume":"59","author":"Yang","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.111067_bib35","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1109\/JBHI.2020.2977009","article-title":"A deep learning-based chemical system for QSAR prediction","volume":"24","author":"Hu","year":"2020","journal-title":"IEEE J. Biomed. Health Inform"},{"key":"10.1016\/j.compbiomed.2025.111067_bib36","author":"Guo"},{"key":"10.1016\/j.compbiomed.2025.111067_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"GNINA 1.0: molecular docking with deep learning","volume":"13","author":"McNutt","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2025.111067_bib38","author":"Wallach"},{"key":"10.1016\/j.compbiomed.2025.111067_bib39","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae416","article-title":"ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries","volume":"40","author":"Swanson","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2025.111067_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-6634-9_5","article-title":"Computer-aided drug design methods","volume":"1520","author":"Yu","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib42","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.drudis.2020.12.013","article-title":"Applications of artificial intelligence in drug development using real-world data","volume":"26","author":"Chen","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2025.111067_bib43","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.compbiomed.2025.111067_bib44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2025.111067_bib45","series-title":"Artificial Intelligence in the Age of Nanotechnology","first-page":"42","article-title":"Artificial intelligence and machine learning in drug discovery and development","author":"Garg","year":"2024"},{"key":"10.1016\/j.compbiomed.2025.111067_bib46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/protein\/2.7.521","article-title":"Prediction of \u03b2-turns in proteins using neural networks","volume":"2","author":"Mcgregor","year":"1989","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.compbiomed.2025.111067_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0022-2836(90)90154-E","article-title":"Improvements in protein secondary structure prediction by an enhanced neural network","volume":"214","author":"Kneller","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1073\/pnas.86.1.152","article-title":"Protein secondary structure prediction with a neural network","volume":"86","author":"Holley","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiomed.2025.111067_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/nar\/19.2.313","article-title":"Training back-propagation neural networks to define and detect DNA- binding sites","volume":"19","author":"O\u2019neill","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib50","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1093\/nar\/18.16.4797","article-title":"Neural network detects errors in the assignment of mRNA splice sites","volume":"18","author":"Brunak","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/07391102.1989.10506540","article-title":"Neural network models for promoter recognition","volume":"6","author":"Lukashin","year":"1989","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2025.111067_bib52","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/nar\/19.7.1593","article-title":"Neural network optimization for E.coli promoter prediction","volume":"19","author":"Demeler","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.1411538","article-title":"Neural computing in cancer drug development: predicting mechanism of action","volume":"258","author":"Weinstein","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2025.111067_bib54","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/pro.5560030924","article-title":"A neural network model for the prediction of membrane\u2010spanning amino acid sequences","volume":"3","author":"Lohmann","year":"1994","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0282(199601)38:1<13::AID-BIP2>3.0.CO;2-Z","article-title":"Structure optimization of an artificial neural filter detecting membrane-spanning amino acid sequences","volume":"38","author":"Lohmann","year":"1996","journal-title":"Biopolymers"},{"key":"10.1016\/j.compbiomed.2025.111067_bib56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bcp.2005.05.017","article-title":"Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein","volume":"70","author":"Zhang","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2174\/1386207318666150525094503","article-title":"Classification of Breast Cancer Resistant Protein (BCRP) inhibitors and non-inhibitors using machine learning approaches","volume":"18","author":"Belekar","year":"2015","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.compbiomed.2025.111067_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1087057116657513","article-title":"Virtual screening of DrugBank reveals two drugs as new BCRP inhibitors","volume":"22","author":"Montanari","year":"2016","journal-title":"Slas Discovery: Adv. Sci. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111067_bib59","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/cancers11091235","article-title":"Cancer diagnosis using deep learning: a bibliographic review","volume":"11","author":"Munir","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2025.111067_bib60","series-title":"Proceedings of the 22nd ACM SIGKDD, International Conference on Knowledge Discovery and Data Mining (KDD '16)","first-page":"785","article-title":"XGBoost: a scalable tree boosting system","author":"Chen","year":"2016"},{"key":"10.1016\/j.compbiomed.2025.111067_bib61","article-title":"A unified approach to interpreting model predictions","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.compbiomed.2025.111067_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1087273","article-title":"A machine learning-based approach to ER\u03b1 bioactivity and drug ADMET prediction","volume":"13","author":"An","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.compbiomed.2025.111067_bib63","doi-asserted-by":"crossref","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","article-title":"DeepDTA: deep drug\u2013target binding affinity prediction","volume":"34","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2025.111067_bib64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acs.jcim.7b00650","article-title":"K deep: protein\u2013ligand absolute binding affinity prediction via 3D-convolutional neural networks","volume":"58","author":"Jim\u00e9nez","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.111067_bib65","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1021\/acs.jcim.9b00628","article-title":"Graph convolutional neural networks for predicting drug-target interactions","volume":"59","author":"Torng","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.111067_bib66","article-title":"CAD and AI for breast cancer\u2014recent development and challenges","volume":"93","author":"Chan","year":"2020","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddtec.2020.11.009","article-title":"A compact review of molecular property prediction with graph neural networks","volume":"37","author":"Wieder","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1109\/TNNLS.2020.2978386","article-title":"A comprehensive survey on graph neural networks","volume":"32","author":"Wu","year":"2021","journal-title":"IEEE Transact. Neural Networks Learn. Syst."},{"key":"10.1016\/j.compbiomed.2025.111067_bib69","first-page":"5879","article-title":"Graph self-supervised learning: a survey","volume":"35","author":"Liu","year":"2023","journal-title":"IEEE Trans. Knowl. Data Eng."},{"key":"10.1016\/j.compbiomed.2025.111067_bib70","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1109\/JSTSP.2022.3207050","article-title":"Self-supervised speech representation learning: a review","volume":"16","author":"Mohamed","year":"2022","journal-title":"IEEE J. Sel. Top. Signal Process."},{"key":"10.1016\/j.compbiomed.2025.111067_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab109","article-title":"An effective self-supervised framework for learning expressive molecular global representations to drug discovery","volume":"22","author":"Li","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2025.111067_bib72","series-title":"Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, Volume 1 (Long and Short Papers)","first-page":"4171","article-title":"BERT: pre-training of deep bidirectional transformers for language understanding","author":"Devlin","year":"2019"},{"key":"10.1016\/j.compbiomed.2025.111067_bib73","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/bioinformatics\/btac020","article-title":"ProteinBERT: a universal deep-learning model of protein sequence and function","volume":"38","author":"Brandes","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2025.111067_bib74","article-title":"Artificial intelligence for breast cancer: implications for diagnosis and management","volume":"3","author":"AlSamhori","year":"2024","journal-title":"J. Med. Surg. Public Health"},{"key":"10.1016\/j.compbiomed.2025.111067_bib75","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s12672-024-01671-0","article-title":"Research trends on AI in breast cancer diagnosis, and treatment over two decades","volume":"15","author":"Singh","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib76","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4048\/jbc.2023.26.e45","article-title":"Artificial intelligence in breast cancer diagnosis and personalized medicine","volume":"26","author":"Ahn","year":"2023","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.compbiomed.2025.111067_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/0115701638262066231030052520","article-title":"Artificial intelligence for the management of breast cancer: an overview","volume":"21","author":"Gandhi","year":"2024","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib78","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3390\/diagnostics13122041","article-title":"Artificial intelligence applications in breast imaging: current status and future directions","volume":"13","author":"Taylor","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.compbiomed.2025.111067_bib79","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acscentsci.0c00229","article-title":"Deep docking: a deep learning platform for augmentation of structure based drug discovery","volume":"6","author":"Gentile","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drudis.2021.09.007","article-title":"Machine-learning methods for ligand\u2013protein molecular docking","volume":"27","author":"Crampon","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2025.111067_bib81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10462-024-10731-4","article-title":"Machine learning heralding a new development phase in molecular dynamics simulations","volume":"57","author":"Pra\u0161nikar","year":"2024","journal-title":"Artif. Intell. Rev."},{"key":"10.1016\/j.compbiomed.2025.111067_bib82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/157340910790980151","article-title":"Pharmacophore based drug design approach as a practical process in drug discovery","volume":"6","author":"Gao","year":"2010","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.compbiomed.2025.111067_bib83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors","volume":"16","author":"Ashkenazi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111067_bib84","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1093\/bioinformatics\/bty374","article-title":"Development and evaluation of a deep learning model for protein\u2013ligand binding affinity prediction","volume":"34","author":"Stepniewska-Dziubinska","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2025.111067_bib85","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acs.jcim.6b00740","article-title":"Protein\u2013ligand scoring with convolutional neural networks","volume":"57","author":"Ragoza","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.111067_bib86","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.2174\/092986712801661112","article-title":"Structure and ligand based drug design strategies in the development of novel 5-LOX inhibitors","volume":"19","author":"Aparoy","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib87","doi-asserted-by":"crossref","first-page":"bbaa321","DOI":"10.1093\/bib\/bbaa321","article-title":"Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets","volume":"22","author":"Wu","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2025.111067_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200186","article-title":"A comparison between 2D and 3D descriptors in QSAR modeling based on bio-active conformations","volume":"42","author":"Bahia","year":"2023","journal-title":"Mol. Inf."},{"key":"10.1016\/j.compbiomed.2025.111067_bib89","first-page":"1","article-title":"3D-QSARpy: combining variable selection strategies and machine learning techniques to build QSAR models","volume":"59","author":"Silverio","year":"2023","journal-title":"Brazilian J. Pharm. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib90","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.2174\/092986712802884259","article-title":"Machine learning techniques and drug design","volume":"19","author":"Gertrudes","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib91","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.3390\/molecules27092823","article-title":"Human estrogen receptor alpha antagonists, part 3: 3-D pharmacophore and 3-D QSAR guided brefeldin A hit-to-lead optimization toward new breast cancer suppressants","volume":"27","author":"Kurtanovi\u0107","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2025.111067_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134487","article-title":"An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: insight into structure activity relationship","volume":"1274","author":"Gupta","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiomed.2025.111067_bib93","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1039\/D2RA00432A","article-title":"In silico prediction and interaction of resveratrol on methyl-CpG binding proteins by molecular docking and MD simulations study","volume":"12","author":"Sahu","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2025.111067_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115075","article-title":"Design, synthesis and biological evaluation of quercetin derivatives as novel \u03b2-catenin\/B-cell lymphoma 9 protein\u2212protein interaction inhibitors","volume":"247","author":"Shen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib95","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.3390\/app11104451","article-title":"Bioactive compounds from herbal medicine targeting multiple myeloma","volume":"11","author":"Cotoraci","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib96","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/1535-7163.MCT-10-0991","article-title":"Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors","volume":"10","author":"Xia","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.compbiomed.2025.111067_bib97","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40265-019-01161-6","article-title":"Alpelisib: first global approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.compbiomed.2025.111067_bib98","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s40265-017-0840-z","article-title":"Abemaciclib: first global approval","volume":"77","author":"Kim","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.compbiomed.2025.111067_bib99","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s40265-017-0742-0","article-title":"Ribociclib: first global approval","volume":"77","author":"Syed","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.compbiomed.2025.111067_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106830","article-title":"Machine learning model for anti-cancer drug combinations: analysis, prediction, and validation","volume":"194","author":"Zhou","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib101","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/1538-7445.AM2021-1461","article-title":"PHI- 101, a potent and novel inhibitor of CHK2 in ovarian and breast cancer cells","volume":"81","author":"Han","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib102","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","article-title":"A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib) relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells","volume":"64","author":"Wood","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib103","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fphar.2020.00733","article-title":"Discovering anti-cancer drugs via computational methods","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib104","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1093\/cid\/ciad538","article-title":"The future ain't what it used to be\u2026 out with the old\u2026 in with the better: Antibacterial resistance leadership group innovations","volume":"77","author":"Evans","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.compbiomed.2025.111067_bib105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s12010-018-2863-7","article-title":"Probing gallate-mediated selectivity and high- affinity binding of epigallocatechin gallate: a way-forward in the design of selective inhibitors for anti-apoptotic Bcl-2 proteins","volume":"187","author":"Olotu","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib106","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/884\/1\/012072","article-title":"Computer aided drug design","volume":"884","author":"Jain","year":"2017","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.compbiomed.2025.111067_bib107","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/17460441.2019.1646245","article-title":"Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers","volume":"14","author":"Spinello","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111067_bib108","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bph.13798","article-title":"Drug repurposing from the perspective of pharmaceutical companies","volume":"175","author":"Cha","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib109","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fchem.2020.00343","article-title":"Structure-based virtual screening: from classical to artificial intelligence","volume":"8","author":"Maia","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib110","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1038\/s41467-021-26023-2","article-title":"Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams","volume":"12","author":"Shen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2025.111067_bib111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41746-024-01368-2","article-title":"A real-world evaluation of an innovative artificial intelligence tool for population-level breast cancer screening","volume":"8","author":"Adapa","year":"2025","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.compbiomed.2025.111067_bib112","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1200\/CCI.20.00051","article-title":"Provider engagement in radiation oncology data science: workshop report","volume":"4","author":"Jain","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.compbiomed.2025.111067_bib113","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3390\/life12121991","article-title":"Artificial intelligence in cancer research: trends, challenges and future directions","volume":"12","author":"Sebastian","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.compbiomed.2025.111067_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1465720","article-title":"Empowering precision medicine: regenerative AI in breast cancer","volume":"14","author":"Bhattacharya","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1192843","article-title":"Unveiling the genomic landscape of possible metastatic malignant transformation of teratoma secondary to cisplatin-chemotherapy: a tempus gene analysis-based case report literature review","volume":"13","author":"Farag","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib116","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JOP.18.00661","article-title":"Implementing precision medicine in community-based oncology programs: three models","volume":"15","author":"Levit","year":"2019","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.compbiomed.2025.111067_bib117","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s42979-023-01771-8","article-title":"Software-tool support for collaborative, virtual, multi-site molecular tumor boards","volume":"4","author":"Schapranow","year":"2023","journal-title":"SN Comput. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib118","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41588-023-01465-0","article-title":"Genome-wide prediction of disease variant effects with a deep protein language model","volume":"55","author":"Brandes","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.compbiomed.2025.111067_bib119","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111067_bib120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-021-00826-3","article-title":"Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer's disease","volume":"13","author":"Tsuji","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.compbiomed.2025.111067_bib121","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","article-title":"Automatic chemical design using a data-driven continuous representation of molecules","volume":"4","author":"G\u00f3mez-Bombarelli","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18332\/pne\/191736","article-title":"Risks of Artificial Intelligence (AI) in medicine","volume":"37","author":"Siafakas","year":"2024","journal-title":"Pneumon"},{"key":"10.1016\/j.compbiomed.2025.111067_bib123","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1021\/acs.accounts.0c00713","article-title":"Black-box optimization for automated discovery","volume":"54","author":"Terayama","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.compbiomed.2025.111067_bib124","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/ph16060891","article-title":"The role of AI in drug discovery: challenges, opportunities, and strategies","volume":"16","author":"Blanco-Gonz\u00e1lez","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiomed.2025.111067_bib125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/proteomes11040034","article-title":"Multi-omics integration for the design of novel therapies and the identification of novel biomarkers","volume":"11","author":"Ivanisevic","year":"2023","journal-title":"Proteomes"},{"key":"10.1016\/j.compbiomed.2025.111067_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1331062","article-title":"Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities","volume":"15","author":"Gangwal","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111067_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep reinforcement learning for de novo drug design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.compbiomed.2025.111067_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2022.1002535","article-title":"Quantum-based machine learning and AI models to generate force field parameters for drug-like small molecules","volume":"9","author":"Mudedla","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nrd941","article-title":"Integration of virtual and high-throughput screening","volume":"1","author":"Bajorath","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111067_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108181","article-title":"Multi-party collaborative drug discovery via federated learning","volume":"171","author":"Huang","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2025.111067_bib131","doi-asserted-by":"crossref","first-page":"35796","DOI":"10.1109\/ACCESS.2024.3373195","article-title":"Explainable artificial intelligence for drug discovery and development: a comprehensive survey","volume":"12","author":"Alizadehsani","year":"2024","journal-title":"IEEE Access"},{"key":"10.1016\/j.compbiomed.2025.111067_bib132","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","article-title":"Artificial intelligence for clinical trial design","volume":"40","author":"Harrer","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.compbiomed.2025.111067_bib133","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.2174\/0109298673290777240301071513","article-title":"Artificial intelligence application for anti-tumor drug synergy prediction","volume":"31","author":"Peng","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111067_bib134","doi-asserted-by":"crossref","first-page":"34183","DOI":"10.1007\/s11042-023-16349-y","article-title":"A comparative analysis of classical machine learning and deep learning techniques for predicting lung cancer survivability","volume":"82","author":"Huang","year":"2023","journal-title":"Multimed. Tool. Appl."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525014192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525014192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:35:46Z","timestamp":1780302946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525014192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":134,"alternative-id":["S0010482525014192"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111067","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in breast cancer therapy: Integrating AI tools for drug discovery and clinical trials","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111067"}}